ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

BOC Sciences New Promotes: Comprehensive Oligo Synthesis Service Package

By: Get News
There are several new varieties of oligo synthesis services launched by BOC Sciences in the past few months, greatly enriching its synthesis service package.

New York, USA – June 21, 2022 – BOC Sciences has nurtured a renowned sub-brand, BOC RNA, that focuses on RNA technology and its broad prospects in drug discovery. RNA-related technologies have been a high-profile area in the life science industry and certainly have attracted much attention from BOC Sciences. After years of accumulation and expansion, it is now competent to offer all-sided services covering the whole development process of RNA drugs.

Oligonucleotides and derivatives served as the starting points for many molecular biology and synthetic biology applications. From genetic testing to forensic research and next-generation sequencing, oligos are broadly used to support the ground-breaking research that is making the world healthier, cleaner, and safer. Therefore, it’s critical to choose a manufacturer that can greatly advance researchers’ oligo exploration journey.

BOC Sciences progressively becomes a reliable oligo synthesis partner with a comprehensive portfolio of synthesis services available for diverse needs. Whether researchers and entrepreneurs are just starting to consider in-house production or are scaling up current operations, BOC Sciences’ technical team can meet where they are to offer guidance and customized recommendations.

“No matter the application, our diverse offerings, proven quality, and solution-driven customer services help ensure a reliable and simplified path for GMP oligonucleotide production,” a technician of BOC Sciences said.

According to a newly released report of BOC Sciences, its synthesis services can cover both natural or non-natural oligonucleotides and derivatives, including DNA/RNA oligonucleotide, ASO, siRNA, miRNA, and aptamer. In more detail, about 40 types of chemical modifications and hundreds of common modifications are available to satisfy customer needs in sequence synthesis and customizations. Additionally, its oligo purification skills, also known as PAGE purification and HPLC purification, span from milligram to kilogram levels to support different applications.

Intending to improve oligo synthesis efficiency and reduce customer waiting time, BOC Sciences has also made every effort to standardize its workflows, from promptly responding to incoming orders to timely product delivery. Every stage is well-designed thus presenting the best results to customers.

“We have established a comprehensive platform and nearly perfect workflow. However, our professional team has always been pursuing more breakthroughs rather than standing still,” the technician added. BOC Sciences is now planning to optimize its platform in the following aspects: more synthetic flexibility in scales, more options in modifications & labelings, and more competitive prices.

To learn more information about the leading biotech company, please visit https://rna.bocsci.com.

About

BOC Sciences is an expert in RNA-related technologies. It provides an extensive collection of RNA products and services, especially the featured custom RNA synthesis. With years of experience and a dedicated research team, BOC Sciences has boosted numerous programs of RNA drug and vaccine discovery.

Media Contact
Company Name: BOC Sciences
Contact Person: Alex Brown
Email: Send Email
Phone: 1-631-485-4226
Country: United States
Website: https://rna.bocsci.com

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.